Back to search
FDAFDA · Food and drugs·Recall number D-0946-2023

Cromolyn Sodium Oral Solution (Concentrate) 100 mg/5 mL 96 Plastic Ampules per carton, Rx Only, For Oral Use Only - Not For Inhalation or Injection, Must be Diluted, Manufactured by: The Ritedose Corporation Columbia, SC 29203 for Ritedose Pharmaceuticals, LLC Columbia, SC 29203, NDC 76204-025-96.

Published August 9, 2023 · Recall initiated: July 21, 2023

Summary

FDA records drug Class II recall D-0946-2023, published August 9, 2023 and initiated July 21, 2023. Recalling firm: The Ritedose Corporation; Status: Completed; Reported quantity: 44 cartons; Lot: Lot: 23CE2, Exp. 03/31/2026. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Completed — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

CGMP deviation: product released prior to supplier approval.

What to do

Voluntary: Firm initiated · E-Mail

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
The Ritedose Corporation
Distributor
Nationwide in the US
Lot
Lot: 23CE2, Exp. 03/31/2026
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Cromolyn Sodium Oral Solution (Concentrate) 100 mg/5 mL 96 Plastic Ampules per carton, Rx Only, For Oral Use Only - Not For Inhalation or Injection, Must be Diluted, Manufactured by: The Ritedose Corporation Columbia, SC 29203 for Ritedose Pharmaceuticals, LLC Columbia, SC 29203, NDC 76204-025-96. recalled?

Yes. FDA published recall D-0946-2023 on August 9, 2023. Reported hazard: CGMP deviation: product released prior to supplier approval.

What should I do if I have this product?

Voluntary: Firm initiated · E-Mail